US Patent 8012931 Modified FGF-21 polypeptides and their uses

Patent 8012931 was granted and assigned to Ambrx on September, 2011 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

September 6, 2011

Patent Application Number

12051830

Date Filed

March 19, 2008

Patent Citations Received

Patent Primary Examiner

Patent abstract

Modified FGF-21 polypeptides and uses thereof are provided.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 8012931 Modified FGF-21 polypeptides and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.